Health and Wellness

STAT+: Those living near the ocean face greater microplastic risk, study finds

CDC leaders recently held their first all-staff meeting since the beginning of the Trump administration, with interim leadership aiming to boost morale and address concerns within the agency. Amidst ongoing

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.

Lasted Health and Wellness

Using AI To Personalize Healthcare–Without Losing Patient Trust

This week’s InnovationRx explores the potential and hurdles of using AI to tailor healthcare and expedite clinical trials, the future

STAT+: At AACR, talk of Chinese biotech, oncology’s comms issue, and more

Welcome to the web version of STAT's popup newsletter, AACR in 30 seconds, your quick overview of the happenings at

Allowing Our Military To Refuse Flu Vaccination Is A Bad Idea. Here’s Why

WASHINGTON, DC - Secretary of War Pete Hegseth (Photo by Anna Moneymaker/Getty Images)Getty ImagesOn Tuesday, April 20, Secretary of War

AACR in 30 Seconds: Revolution Medicines data, NCI director, wildfires

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021

There’s No Such Thing As Brain Honey

Social media is awash with false claims, including a fabricated CNN image, suggesting that a honey-based product can cure Alzheimer's

RFK Jr. faces GOP doctors led by Cassidy at Senate hearings

This is the web edition of D.C. Diagnosis, STAT's newsletter offered twice a week, focusing on health and medicine politics

AI Is Already Here. The Real Risk In Public Health Is Sitting It Out

Electronic brain and Concept of artificial intelligence(AI).Graphic of a digital brain and Human head outline made from circuit board, connecting

AACR in 30 Seconds: CAR-T promise, Merck’s new move, rural health

Angus Chen reports on a wide range of cancer-related topics, including drugs, policy, science, and equity. He started working with